These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34978580)

  • 1. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
    Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
    Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses.
    van Nederpelt DR; Amiri H; Brouwer I; Noteboom S; Mokkink LB; Barkhof F; Vrenken H; Kuijer JPA
    Neuroradiology; 2023 Oct; 65(10):1459-1472. PubMed ID: 37526657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
    Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
    Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
    Storelli L; Pagani E; Pantano P; Piervincenzi C; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
    J Magn Reson Imaging; 2023 Oct; 58(4):1221-1231. PubMed ID: 36661195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
    Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.
    Vidal-Jordana A; Pareto D; Sastre-Garriga J; Auger C; Ciampi E; Montalban X; Rovira A
    AJNR Am J Neuroradiol; 2017 Feb; 38(2):250-256. PubMed ID: 27884876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmortem validation of MRI cortical volume measurements in MS.
    Popescu V; Klaver R; Versteeg A; Voorn P; Twisk JW; Barkhof F; Geurts JJ; Vrenken H
    Hum Brain Mapp; 2016 Jun; 37(6):2223-33. PubMed ID: 26945922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis.
    Warntjes JB; Tisell A; Landtblom AM; Lundberg P
    AJNR Am J Neuroradiol; 2014 Jul; 35(7):1330-6. PubMed ID: 24699093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis.
    Liu Y; Lukas C; Steenwijk MD; Daams M; Versteeg A; Duan Y; Li K; Weiler F; Hahn HK; Wattjes MP; Barkhof F; Vrenken H
    AJNR Am J Neuroradiol; 2016 Apr; 37(4):749-54. PubMed ID: 26659338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
    Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
    J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
    Guo C; Ferreira D; Fink K; Westman E; Granberg T
    Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study.
    Margoni M; Pagani E; Preziosa P; Gueye M; Azzimonti M; Rocca MA; Filippi M
    J Neurol; 2023 Aug; 270(8):3839-3850. PubMed ID: 37093395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
    Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
    PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.